News
Dr. Cristóbal Orellana, Associate Physician at the Service of Rheumatology of the Parc Taulí Hospital (Sabadell, Barcelona) commented that biomarkers extracted from type II collagen, a type of collagen that can be found only in the cartilage, holds great promise for diagnosing osteoarthritis, and for monitoring its treatment.
Genetics, key to predict the progression of osteoarthritis
A clinical trial by Prof. Jean-Pierre Pelletier has been published in Annals of the Rheumatic Diseases this week
Immunactive is a nutritional supplement containing an exclusive formulation of nucleotides that helps stimulate the body's own defenses.
In 2009, Immunactive was launched on the Spanish market, where it has earned itself a highly favourable reception. The next step is to enter the international market.
The Bioiberica Joint Care Division has so far focused on the therapeutic field of joint care. In recent years, however, Bioiberica has worked intensively on developing a product line aimed at immune and digestive health. Our consolidation in this area means we can widen our range of products and services: